Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCMs for COVID-19 Infection
NCT04251871Unknown
- Sponsor
- The Fifth Medical Center of the PLA General Hospital
- Start
- Jan 2020
- Primary completion
- Jan 2021
- Modality
- HMF (Herbal Medicine Formulation)
- Countries
- 1
01
Overview
Randomised, open-label trial of bazhengsan in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by The Fifth Medical Center of the PLA General Hospital. Primary endpoint: The incidents of acute respiratory distress syndrome (ARDS) development at 14 days. Status: unknown.
02
Drugs
bazhengsan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04251871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04251871.